Rapid and efficient preparation of monoclonal antibodies against 35 kDa lipoprotein of Mycoplasma penetrans

被引:8
作者
Ferraz, Aline S. [1 ]
Belo, Elza F. T. [1 ]
Coutinho, Ligia M. C. C. [1 ]
Oliveira, Ana P. [1 ]
De Gaspari, Elizabeth N. [1 ]
机构
[1] Adolfo Lutz Inst, Immunol Sect, BR-01246902 Sao Paulo, Brazil
来源
HYBRIDOMA | 2007年 / 26卷 / 02期
关键词
D O I
10.1089/hyb.2006.046
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To develop a rapid and efficient method for preparing monoclonal antibodies ( MAb) against 35 kDa lipoprotein of Mycoplasma penetrans, BALB/ c mice were injected into the footpads for immunization, and the popliteal lymph nodes were isolated 19 days later for MAb- producing hybridomas, from which the mAbs against the 35kDa lipoprotein were screened. The identification of the mAb against the 35 kDa lipoprotein was performed using indirect enzyme- linked immunosorbent assay ( ELISA) and immunoblotting. Using popliteal lymph node procedures, we generated several positive clones, one of which we characterized by ELISA and immunoblot. The clone 1D41B8 was identified as the immunoglobulin G1 ( IgG1) isotype, kappa chain with affinity constants ( Ka) of 2.95 x 10(9)M(-1). The MAbs did not cross- react with a number of control bacteria, which included Mycoplasma fermentans, Mycoplasma hominis, and Mycoplasma genitalium. This is the first report on the preparation of mAbs against M. penetrans that is specific to 35 kDa lipoprotein using popliteal lymph nodes. The high- specificity and high- affinity MAbs produced by two methodologies used of hybridomas provide a basis for further research on the pathogenesis and early diagnosis of M. penetrans. This simple approach may become a method of choice for the generation and production of MAbs in a short period of time.
引用
收藏
页码:92 / 97
页数:6
相关论文
共 29 条
[21]   Considerations for in vitro monoclonal antibody production [J].
Peterson, NC .
RESEARCH IN IMMUNOLOGY, 1998, 149 (06) :553-557
[22]  
READING CL, 1982, J IMMUNOL METHODS, V30, P53
[23]   Use of monoclonal antibody against V. cholerae Serovar O1. [J].
Ristori, Cristiane ;
Rowlands, Ruth ;
Jakabi, Mioco ;
Gelli, Dilma ;
De Gaspari, Elizabeth .
CLINICAL IMMUNOLOGY, 2006, 119 :S153-S153
[24]  
Rosengarten R, 2000, INT J MED MICROBIOL, V290, P15
[25]   Phase variation among major surface antigens of Mycoplasma penetrans [J].
Röske, K ;
Blanchard, A ;
Chambaud, I ;
Citti, C ;
Helbig, JH ;
Prevost, MC ;
Rosengarten, R ;
Jacobs, E .
INFECTION AND IMMUNITY, 2001, 69 (12) :7642-7651
[26]  
Schelling M E, 1995, Methods Mol Biol, V45, P9, DOI 10.1385/0-89603-308-2:9
[27]   Cesar Milstein, the father of modern immunology - In memoriam [J].
Springer, TA .
NATURE IMMUNOLOGY, 2002, 3 (06) :501-503
[28]   Improved purification of native meningococcal porin (Por B) and studies using intranasal route in neonates mouse. [J].
Teixeira, Mariana ;
De Gaspari, Elizabeth .
CLINICAL IMMUNOLOGY, 2006, 119 :S178-S178
[29]   Mycoplasma penetrans bacteremia and primary antiphospholipid syndrome [J].
Yañez, A ;
Cedillo, L ;
Neyrolles, O ;
Alonso, E ;
Prévost, MC ;
Rojas, J ;
Watson, HL ;
Blanchard, A ;
Cassell, GH .
EMERGING INFECTIOUS DISEASES, 1999, 5 (01) :164-167